Regional scale Novartis Australia & New Zealand operates with a sizable employee base and a broad patient reach, presenting opportunities to partner on locally accessible clinical trials, patient support programs, and market access initiatives to accelerate adoption of new therapies.

Pipeline activity With 50+ ongoing Phase III programs and a focus on innovative science, there is potential to collaborate on research services, regulatory strategy, and regional trials management to expand access and reduce time-to-market for new treatments.

Diversity & inclusion A family-friendly, DEI-driven culture supports sustainable talent sourcing and regional workforce development initiatives that can be aligned with partner programs, patient advocacy outreach, and local health outcomes projects.

Digital & compliance Adoption of technologies and standards such as ISO 50001 and ISO 9001, along with data platforms like Ataccama and IBM Spectrum LSF, signals readiness for data-driven trials, quality optimization, and scalable analytics collaborations.

Expansion signals Recent news about facility expansion in the United States and strategic partnerships indicate growth momentum and potential for cross-border collaborations, co-development, and regional manufacturing or logistics partnerships to support supply chain resilience.